ERBB2 and breast cancer: TNBC is a highly heterogeneous and highly aggressive BC subtype characterized by the lack of expression of hormone receptors (HR) and human epidermal growth factor receptor 2 (HER2) (Lehmann et al., 2011; Sorlie et al., 2001).